4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001171843-15-006901
Options or other derivatives
- VP of Clinical Development acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GOLDBERG Y. PAUL · VP of Clinical Development
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-12-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +15,000 | $7.69 | 2025-12-17 | 15,000 | 15,000 | D |
Loading xslF345X03/gff4_goldberg121815.xml…